U.K. Drug Industry Cuts Prices By 4.5% To National Health Service
Executive Summary
U.K. pharmaceutical companies must reduce the prices of products supplied to the National Health Service by 4.5%, under the new pharmaceutical price regulation scheme package (PPRS) negotiated by the Association of the British Pharmaceutical Industry and the U.K. Department of Health.